Munafa Stock Market Course + Intraday & FNO calls 
Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for NASDAQ stock HALO Halozyme Therapeutics. Dated: 13 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 67.55 and Closed at: 66.98, which is -1.25% of previous session's close. It moved within a range of 66.20 and 68.05
The session was a Bearish session with an average volume of 1042900, which is 4.09% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 65.67 and resistance for tomorrow is 67.52
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 66.1, 65.23 resistance for tomorrow's hourly charts is 67.95, 68.93
10 Day SMA for Halozyme Therapeutics (HALO) is 65.07 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 64.17 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 69.53 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 69.22 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 67.83 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 64.17 and 200 DMA is at 67.83, while 50 DMA and 100 DMA are at 69.53 and 69.22 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 64.17 and 20 EMA is at 65.49
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Apr | 66.98 | 64.17 | 65.49 |
| 10 Fri Apr | 67.82 | 64 | 65.33 |
| 09 Thu Apr | 67.08 | 63.94 | 65.07 |
| 08 Wed Apr | 65.43 | 63.97 | 64.86 |
| 07 Tue Apr | 63.62 | 64.11 | 64.8 |
| 06 Mon Apr | 63.08 | 64.29 | 64.92 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 69.53 and 50 EMA is at 67.39
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Apr | 66.98 | 69.53 | 67.39 |
| 10 Fri Apr | 67.82 | 69.66 | 67.41 |
| 09 Thu Apr | 67.08 | 69.76 | 67.39 |
| 08 Wed Apr | 65.43 | 69.82 | 67.4 |
| 07 Tue Apr | 63.62 | 69.91 | 67.48 |
| 06 Mon Apr | 63.08 | 70.02 | 67.64 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 69.22 and 100 EMA is at 68.22
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Apr | 66.98 | 69.22 | 68.22 |
| 10 Fri Apr | 67.82 | 69.25 | 68.25 |
| 09 Thu Apr | 67.08 | 69.28 | 68.26 |
| 08 Wed Apr | 65.43 | 69.32 | 68.28 |
| 07 Tue Apr | 63.62 | 69.37 | 68.34 |
| 06 Mon Apr | 63.08 | 69.41 | 68.44 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 67.83 and 200 EMA is at 66.9
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Apr | 66.98 | 67.83 | 66.9 |
| 10 Fri Apr | 67.82 | 67.75 | 66.9 |
| 09 Thu Apr | 67.08 | 67.68 | 66.89 |
| 08 Wed Apr | 65.43 | 67.61 | 66.89 |
| 07 Tue Apr | 63.62 | 67.55 | 66.9 |
| 06 Mon Apr | 63.08 | 67.5 | 66.93 |
Zai Lab has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Zai Lab, about 10.95% more returns!
Vericel Corporation has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Vericel Corporation, about 0.65% more returns!
United Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in United Therapeutics, about 2.52% more returns!
Halozyme Therapeutics has performed better than Trupanion Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Tenax Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Surgery Partners has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 0.52% more returns!
Ptc Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 3.98% more returns!
Halozyme Therapeutics has performed better than Merit Medical in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Ligand Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Anaptysbio Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Anaptysbio Inc, about 0.83% more returns!
Ani Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 5.87% more returns!
Halozyme Therapeutics has performed better than Arvinas Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Axsome Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 9.04% more returns!
Capricor Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 8.03% more returns!
Crispr Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 7.27% more returns!
Halozyme Therapeutics has performed better than Eyegate Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Icon Plc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 7.02% more returns!
Halozyme Therapeutics has performed better than Incyte Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Iradimed Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Halozyme Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 65.03 and Halozyme Therapeutics HALO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
